Form 4: Third Harmonic Bio CEO Natalie Holles Exercises Options and Sells Shares
SEC Form 4 Filing
Third Harmonic Bio CEO Natalie Holles exercised stock options and sold shares on May 9, 2024, according to a Form 4 filing with the SEC.
Summary
- On May 9, 2024, Natalie C. Holles, CEO of Third Harmonic Bio, Inc., exercised employee stock options to acquire 20,222 shares of common stock at a price of $4.20 per share.
- Simultaneously, Holles sold 20,222 shares of common stock at a weighted average price of $12.1798, with prices ranging from $12.15 to $12.42 per share.
- Following these transactions, Holles directly owns 1,218,836 shares of Third Harmonic Bio, Inc.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reflects routine insider trading activity under a pre-arranged plan.
Industry Context
Form 4 filings are standard practice and provide transparency into insider transactions, allowing investors to monitor the actions of company executives and directors.
Key Dates
| Date | Description |
|---|---|
| 05/17/2022 | 6.25% of the total shares vested. |
| 02/16/2032 | Expiration date of the Employee Stock Option. |
| 05/09/2024 | Date of the stock option exercise and share sale. |
| 05/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.